Patients often demand experimental drugs that prove ineffective — report
A new paper by a team of FDA officials finds that only about 30% of drugs requested for expanded access go on to be approved …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
